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ABSTRACT 
 
 
 Stem cell research is a very controversial issue, and many individuals base their decisions 
about whether to support such research on misinformation.  Although embryonic stem (ES) cells 
are the most controversial type of stem cell, many other types of stem cells exist and are being 
researched as potential replacements for therapies.  This IQP investigated the different types of 
stem cells and their applications, as well as the ethics behind the research.  Throughout this 
investigation, it was clear that ES cells provide the most medical potential due to their 
pluripotency, and ease of identification and growth.  However, recent research has developed 
other types of pluripotent cells that may have fewer ethical issues.  After presenting information 
on the science and ethics of this topic, the author provides her own conclusions based on the 
research.  
  
 
3 
TABLE OF CONTENTS 
 
 
Signature Page ………………………………………..………………………………..  1 
Abstract ………………………………………………..……………………………….  2 
Table of Contents ………………………………………..………...…………………...  3 
Project Objectives ………………………………………….…………………………...  4 
Chapter-1: Stem Cell Types ……………...…………..……………..………………….  5 
Chapter-2: Stem Cell Ethics ………………..……..…………………..……………..... 16 
Project Conclusions ………………………………………………….………….…….. 21 
  
 
4 
PROJECT OBJECTIVE 
 
 The overall objective of this IQP was to shed light on the controversial topic of stem 
cells, investigating both stem cell science and issues of the science that affect society, such as 
ethics and legalities.  The first half of the project discussed the different types of stem cells and 
described from where they are derived.  This information serves as a basis of helping determine 
the benefits of stem cells to society.  The second half of the project investigated the ethical issues 
of using stem cells, especially from the point of view of the five major world religions, and 
discussed the topic of whether we should work with these cells.  The final purpose of the project 
was for the author to make her own conclusions about this controversial technology. 
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Chapter-1:  Stem Cell Types 
 
 
 
 Stem cells are different from other cells of the body, they are unspecialized cells that are 
capable of self-renewal.  During normal development, stem cells differentiate into various other 
cell types to eventually form the adult organism.  But stem cells can also be manipulated in vitro 
into developing into specialized cells or tissues.  Thus, stem cells are the basis of the new field of 
regenerative medicine, the replacement of diseased or damaged tissue with new tissue.  
However, stem cells are not all alike, so the purpose of this chapter is to categorize the various 
types of stem cells, paying special attention to how each type is isolated as this strongly affects 
their ethics. 
 
Stem Cells Types and Potencies  
 Stem cells can be categorized into two main types: embryonic stem (ES) cells and adult 
stem cells (ASCs).  ES cells are derived from the inner cell mass of a 5-day old embryo prepared 
by in vitro fertilization (IVF).  Isolating the inner cell mass usually destroys the embryo, so these 
cells are very controversial as their isolation destroys potential life.  Adult stem cells are isolated 
from adult tissues.  This category includes the very well characterized bone marrow stem cells, 
as well as neural stem cells, epithelial stem cells, mesenchymal stem cells, and others.  Their 
isolation does not destroy any embryos, so they have fewer ethical issues.   
 Stem cells can also be categorized based on their potency, or their ability to divide and 
differentiate into other cell types (NIH, 2005, Ch. 1).  Totipotent cells have the ability to develop 
into all the different cell types of the body as well as cells that make up extra-embryonic tissues 
like the placenta.  The newly fertilized egg through the 8-cell stage represent totipotent cells.  
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Pluripotent stem cells can form any cell of the adult organism.  ES cells are pluripotent (NIH, 
2005, Ch. 3).  Multipotent stem cells can give rise to several related cell types, but they are not 
pluripotent.  A good example of a multipotent stem cell is the hematopoietic stem cell that can 
form all the cellular components of blood.  Finally, unipotent stem cells can only differentiate 
into one cell type (Explore Stem Cells, 2010).  Epithelial stem cells are thought to be unipotent. 
 
 
Embryonic Stem Cells 
  
Embryonic stem (ES) cells are the most controversial type of stem cell.  ES cells were 
first discovered in mice in 1981 (Evans and Kaufman, 1981; Martin, 1981), and human ES cells 
were first grown in the laboratory setting in 1998 (Thomson et al., 1998).  ES cells are usually 
derived from the inner cell mass of an in vitro fertilized (IVF) blastocyst.  A blastocyst is a very 
small hollow ball of cells containing three distinct parts: trophoblast, blastocoel, and an inner cell 
mass (NIH, 2005, Ch. 3).  The outer cell layer of the blastocyst is the trophoblast.  The 
trophoblast develops into the placenta.  The blastocoel is a cavity inside the blastocyst that is 
filled with fluid.  The inner cell mass, as indicated by its name, is the inner layer of the 
blastocyst.  This inner layer contains a cluster of cells that later go on to develop into the embryo 
(NIH,  2010).   Embryos at IVF clinics that are not used for reproductive purposes are usually 
discarded.  Depending on the laws in place at the time, and the source of the funds (federal, state, 
or private), these excess embryos can sometimes be used for research purposes with parental 
(donor) consent.  When the blastocyst is around four to five days old post-fertilization, the inner 
cell mass is transferred to a culture dish which is filled with culture media and a feeder layer of 
irradiated cells.  The feeder layer is irradiated to prevent their reproduction, while still allowing 
them serve as a scaffold for ES cell growth.   The ES cells are allowed to divide and spread over 
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this feeder layer.  The growing ES cells are re-plated on several fresh culture dishes to eventually 
create an ES cell line to with millions of  cells.   
Several proteins inside the ES cells act to help them maintain their pluripotency.  These 
proteins can also act as markers for identifying ES cells.  Research is still helping to identify 
these marker proteing, but they include Nanog and Oct4.  Nanog and Oct4 are transcription 
factors that induce the expression of genes that act to help maintain the pluripotent state.   
ES cells have the greatest medical potential due to their pluripotency, their ability to grow 
in large quantities, and their relative ease of isolation compared to adult stem cells (ASCs).  
Thus, many scientists prefer to work with them whenever possible instead of ASCs.  ES cells 
could be used to treat Parkinson’s disease, diabetes, heart disease, or vision and hearing loss 
(NIH, 2005, Ch. 3).  
 
 
Adult Stem Cells 
 
 The second main category of stem cell is the adult stem cell (ASC).  ASCs are also 
sometimes referred to as somatic stem cells, as they are isolated from adult somatic tissues.  
ASCs are not as potent as ES cells; they are thought to be multipotent or unipotent.  ASCs are 
undifferentiated cells found in the mature tissues and organs of the body.  Due to their 
multipotent or unipotent nature, ASCs are less capable of differentiation ES cells (Newton, 
2006).   ASCs were first discovered in the 1950s by researchers who discovered that bone 
marrow contains both hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs).  
Figure 1 shows the differentiation of these two types of marrow ASCs (NIH, 2005, Ch. 4). 
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Figure-1: Diagram of Adult Stem Cell Differentiation in Bone 
Marrow.  Diagram shows the location of hematopoietic stem cells 
(HSCs) and mesenchymal (stromal) stem cells in bone marrow (diagram 
left).  The differentiation of HSCs (diagram center, pink) into myeloid 
and lymphoid cells of the blood is shown in the diagram upper center. 
The differentiation of MSCs into mesodermal tissues such as bone and 
muscle is shown in diagram lower center.  (NIH, 2005, Chapter-4)  
 
 
 
Hematopoietic Stem Cells (HSCs) 
  
 HSCs are the best characterized type of stem cell, as scientists have been studying them 
for decades.  In the 1950s, cells in bone marrow were found to be capable of self-renewal.  
Human HSC transplants have been used since 1957 to treat specific types of blood disorders 
(Thomas et al., 1957).  Today, HSCs can also be isolated from umbilical cord blood, or from 
peripheral blood in individuals pre-treated with hormones to stiumlate HSC release from the 
marrow.  HSCs are identifiable by their surface markers CD34, c-kit, and Thy-1.  These 
multipotent cells can develop into erythrocytes, granulocytes, macrophages, red blood cells, and 
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platelets.  Since HSCs have been known to migrate via the blood to liver, they have also been 
shown to develop into liver cells.  These stem cells offer a wide variety of clinical application 
when it comes to fighting diseases such as leukemia, autoimmune disorders, and genetic diseases 
(Bongso and Lee, 2005).  Figure 2 shows the various differentiation lineages of a HSC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-2: Diagram of Hematopoietic Stem Cell Differentiation.  This 
diagram is similar to figure-1, except it shows  a clearer demarkation of 
the pathways involved in HSC differentiation, including the main 
lymphoid and myeloid lineages.  (Newton, 2006) 
 
 
Mesenchymal Stem Cells  
 
  Mesenchymal stem cells (MSCs) are adult multipotent stem cells that give rise to 
osteoblasts, chondrocytes, and fat cells (Jiang et al., 2002).  Although no markers specific for 
MSCs have been identified, they can be isolated by using antigenic markers like CD90 and 
CD105.  Allowing colonies to form in vitro is the best way to identify cells that can undergo 
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differentiation into mesenchymal cell lines (Bongso and Lee, 2005).  Due to their multipotency, 
relative ease of isolation, and lack of embryo destruction, MSCs are currently a very hot topic of 
research for medical applications. 
 
 
 Neural Stem Cells 
   
  In the 1990s, scientists observed cells in the adult human brain that were able to give rise 
to astrocytes, oligodendrocytes, and neurons (Morshead et al., 1993; Palmer et al., 1997; Temple 
and Alvarez-Buylla, 1999), and these cells were eventually termed neural stem cells (NSCs).  
Astrocytes and oligodendrocytes are non-neuronal cells that function to help neurons to survive 
and make connections (NIH, 2005, Ch. 4).  It now appears that NSCs are multipotent stem cells 
located within the hippocampus and the lateral ventricles of the human adult brain.  Their 
potential use for repairing brain damage after an injury is promising for treating Parkinson’s 
disease, Alzheimer’s disease, and stroke (Bongso and Lee, 2005). 
 
  
Epidermal (Skin) Stem Cells 
  
  In 1985, markers for skin stem cells were first identified and include β1 and β4 integrin, 
and keratins 15, 17, 19 (Sell, 2004).  Kerotinocytes are epithelial cells located within the basal 
layer of the dermis that can divide and differentiate to form a layer on the outer skin as a 
protective barrier from the environment.  These unipotent stem cells are essential for re-growth 
of skin and hair cells.  The ability of epidermal stem cells to re-grow skin cells allows them to be 
used to treat burn victims with skin-grafts (Bongso and Lee, 2005).  
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GI Epithelial Stem Cells 
 
  Epithelial stem cells are a type of adult stem cell found along the epithelial lining of the 
gastrointestinal tract.  Regeneration of the epithelial cells within the tract is aided by these 
multipotent stem cells inside the crypts of Lieberhahn (Bongso and Lee, 2005).  The first insight 
into the renewal rate of the cells along the gastrointestinal tract was accomplished in 1959 with 
the use of radio-thymidine DNA labeling and a radioautographic technique.  There are no 
specific markers yet known for GI stem cells, but they are characterized as being undifferentiated 
with a high ability to proliferate (Sell, 2004).  They can develop into goblet, enteroendocrine, 
paneth, and absorptive cells (NIH, 2005, Ch. 4).  
 
 
 Cardiac Stem Cells 
  
  Although the heart was originally thought to lack regenerative capacity, experiments 
published in 2003 showed that cardiac progenitor cells with some proliferative capacity exist in 
heart muscle (Beltrami et al., 2003; Oh et al., 2003).  These adult stem cells have the capacity to 
regenerate cardiomyocytes.  CSCs were later shown to express the marker protein Isl1 (Laugwitz 
et al., 2005).  The degree to which these cardiac stem cells (CSCs) can aid in improving damaged 
heart muscle is still unclear, but this capacity would be invaluable for patients who have suffered 
a heart attack or other heart diseases (Sell, 2004). 
 
 
 Induced Pluripotent Stem Cells 
  
  The hottest topic in all of stem cell research is induced pluripotent stem (iPS) cells.  In 
2006, iPS cells were first prepared from mouse cells in Yamanaka’s lab in Japan (Vogel, 2006), 
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and in 2007 the same lab first prepared human iPS cells (Takahashi et al., 1997).  iPS cells are 
adult cells (usually skin fibroblast cells) treated with various transcription factor proteins to 
induce their de-differentiation to a pluripotent-like state.  Thus, iPS cells have been genetically 
altered to express genes typical of embryonic stem cells.  The first inductions used a combination 
of 4 different transcription factors, but currently only two are needed, and in particular the 
current treatment omits the use of c-myc which caused the earlier iPS cell batches to create 
tumors upon implantation (Kim et al., 2008).   
The hope of iPS cells is they will prove to be as biologically potent as embryo-derived ES 
cells, but they do not destroy an embryo to obtain them.  Some experiments have shown iPS cells 
appear to be pluripotent, such as expressing ES-like stem cell markers and generating different 
cell types.  But other experiments suggest they may be harder to grow (Dolgin, 2010).  So more 
research is needed to determine their true regenerative abilities.  Since no embryo is being 
created or destroyed to prepare iPS cells, this stem cell type has been of great interest to the 
scientific community as a way to end the ethical dilemma of ES cell usage. 
 
 
 Parthenogenetic Embryonic Stem Cells 
 
  Parthenogenesis is an asexual mode of reproduction found in some insect species, such as 
bees and ants.  This process is used to create worker bees and ants without fertilization; the egg 
is stimulated to divide without the presence of sperm.  Parthenogenesis does not appear to exist 
in mammalian species, but some mammalian eggs can be stimulated in vitro to divide by 
treatment with chemicals or electrical signals.  In monkeys, parthenote eggs have been grown to 
the blastocyst stage, and ES cells lines have been derived from those embryos (Cibelli et al., 
2002).  Although some claims of human parthenogenetic ES cell lines have been published 
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(Brevini and Gandolfi, 2007), those findings have not been reproduced yet.   Because 
mammalian parthenote eggs can not produce an adult organism, some scientists claim these 
embryos are less controversial than normal IVF embryos.  Thus, if parthenote ES cells can ever 
be derived from human eggs, this may be more ethical than working with discarded IVF embryos 
prepared for reproductive purposes. 
 
 
 Chapter-1 Conclusion 
  
  This chapter described the various types of stem cells, and should immediately show the 
reader that not all stem cells are alike.  In particular, the reader should now know that not all 
stem cell research destroys embryos.  It is important to understand the differences between the 
stem cells, especially when dealing with the ethical dilemma of embryonic stem cells.  In chapter 
3, the ethical issues centered on stem cell research will be discussed. 
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CHAPTER-2: STEM CELL ETHICS 
 
  
 
Introduction 
 
  The reason there is so much controversy over stem cell research is that working with ES 
type stem cells destroys embryos to obtain the cells.  And many people incorrectly link all stem 
cell research together, believing that all stem cell research destroys embryos.  In chapter-1, we 
described many different types of stem cells, and only ES cells derived from IVF embryos 
destroyed embryos.  In this chapter, we weigh the potential medical benefit to society against the 
destruction of the embryo, and in particular focus on the stance of the world’s five major 
religions (Christianity, Judaism, Islam, Hinduism, and Buddhism) on stem cell research.   
Interestingly, from the outset we can state that all five major world religions share the 
common trait of being proponents of adult stem cell research (Griffin, 2010).  This favorable 
stance for ASCs even includes the Catholic Pope (Catholic Online, 2008).  Thus, for this chapter 
we will mostly focus on the views of the five major religions on the use of embryos for stem cell 
research.   
The debate invariably focuses on when life begins.  If one argues that life begins at 
conception, as does the Pope, then that individual would be against ES cell research;  the 5-day 
old blastula from which the ES cells are derived would be considered alive by this stance.  On 
the other hand, if you argue that life begins at day 40 or at birth, then your religious beliefs 
would not prevent you from taking an IVF embryo to derive ES cells to save human lives. 
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Christianity on Embryonic Stem Cells 
   
  There are many different sectors of the Christian faith, all with different views on the use 
of embryonic stem cells.  The Roman Catholic Church, currently overseen by Pope Benedict 
XVI, is strongly against the use of embryos for any scientific research.  In the Catholic stance, 
life begins at conception, and the embryo is viewed as a sacred entity of life, whether it exists in 
vivo or in vitro.  The embryo cannot be used for research, as its only purpose is to develop into a 
person ("Teaching About Religion,” 2006).   
  Another main sect of Christianity is Protestantism.  Under this sect, there is even more 
ambiguity on the status of the human embryo.  The Southern Baptist Convention for example 
determined the embryo to be a human person from conception and can therefore not be used for 
research; but the American Presbyterian Church allows research to be conducted on embryos for 
the greater good and if there is no other means to go about the research (Faithful Progressive, 
2005).  For the majority of those under the Protestant religion, the embryo should only be used if 
it is less than 15 days post-conception (which allows research on the blastocyst), so long as the 
embryo is considered excess and will not be used for reproductive IVF purposes ("Teaching 
About Religion,” 2006). 
 
 
 Judaism and Embryonic Stem Cells 
 
  Judaism takes a more lax stance on the status of the fetus.  The Jewish religion views 
embryonic tissue as being “like water,” before the 40th day after conception (Ayon, 2002).  But, 
since the embryo is a part of the mother’s body, it should not be easily dismissed.  Although the 
embryo deserves respect even though it is not a full person, if it can be used to help save lives 
then it should be used.  Therefore, under Jewish law, ES cells from the donation of eggs and 
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sperm that have been mixed and cultured in lab, as well stem cells isolated from an aborted fetus, 
are allowed to be used for scientific research.  These sources of ES cells were not taken from a 
woman’s womb and are therefore not bound to the legal status of the Jewish law.  However, 
these ES cells must be used by professional scientists for the betterment of the common good; 
pikuach nefesh (to save a life) is the Jewish moral standing on medical ethics (Holland et al., 
2001).  
 
 Islam and Embryonic Stem Cells 
  
  Under the Shari’ah (Islamic Law) it can be inferred that ES cell research is permitted 
since a fetus is not viewed as a human person until 40 days after conception (Ahmed, 2001).  
This belief may also permit the use of creating embryos solely for scientific research, as well as 
using excess embryos from IVF clinics (Bongso and Lee, 2005).  
 
 
 Hinduism and Buddhism on Embryonic Stem Cells 
 
  Traditional Hindus believe that the soul is present from the moment of conception.  They 
also believe in reincarnation.  Thus, these Hindus take issue with embryo destruction as each 
embryo represents a former life that is on its way to rebirth.  However, other modern Hindus 
believe that a human being is initially present in the embryo between three and five months after 
conception, and others believe it is not present until the seventh month, so those Hindus would 
allow research on 5-day old embryos (Bahnot, 2008).   
Buddhists have similar beliefs to the traditional Hindu religion on moment of personhood 
as being at the beginning of conception.  And in addition, Buddhists believe in harm reduction.  
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So most Buddhists hold that research on embryos should not be allowed  ("Teaching About 
Religion,” 2006).  
 
  
Ethics of iPS Cells 
 
  Induced pluripotent stem (iPS) cells can offer an alternative to the use of embryo-derived 
ES cells as they represent adult cells that have been genetically altered to act like ES cells 
(discussed in Chapter-1).  These cells are not yet as widely used as other stem cells since their 
discovery was only recent, and their medical potentials have not yet been fully investigated.  
Unlike traditional ES cells, no embryo is created or destroyed in this process, so the ethics of this 
process is similar to working with adult stem cells, and should eventually be supported by all 
major world religions. 
 
 
Chapter-3 Conclusion 
 
  This chapter investigated the stance of the five major world religions on stem cells.  All 
five major religions support the use of adult stem cells, as no embryo is destroyed in this type of 
research yet lives can still be saved.  But adult stem cells do not grow as well as ES cells, they 
are not easy to isolate, nor can they differentiate into as many tissues as ES cells.  So ES cell 
research will continue to gather most of the attention in stem cell research for now.  Although 
some members of two or three of the five major religions support embryo research, most 
members do not.  So adult stem cells should be used to treat a particular disease whenever 
possible, before using ES cells. 
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PROJECT CONCLUSIONS 
 
 
 
Based on the rearch performed for this project, the author is able to make her own 
conclusions about this controversial technology.  With respect to the topic of embryos being used 
for research purposes, the author believes that embryo research should continue.  The author 
does not affiliate with any particular organized religion, and strongly supports the use of 
embryonic stem (ES) cells for the advancement of our medical knowledge, and for clinical 
applications to save human lives.  I believe embryos should be used whether they come from 
excess IVF embryos originally created for reproductive purposes in a fertility clinic or from paid 
donors.   As a nod to those individuals who believe embryo research is wrong, the author agrees 
that adult stem cells (ASCs) should be used to treat a particular disease if possible.  However, if 
ASCs do not work as well as ES cells for a particular disease, ES cells should be used without 
reservation.  And the author feels the same for induced pluripotent stem (iPS) cells, since iPS 
cells do not create or destroy any embryos, so long as they prove to be as pluripotent as ES cells, 
although this point has not yet been proven. 
 
